Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « assessment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
assessing < assessment < assessments  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000080 (2020) Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria GasperiThe “Janus Face” of Platelets in Cancer
000088 (2020) N. Ghalandari ; R. J. E. M. Dolhain ; J. M. W. Hazes ; C. L. E. Siezen ; J. W. Van Der Laan ; H. J. M. J. Crijns ; E. P. Van Puijenbroek ; C. J. Van Der WoudeThe pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
000094 (2020) Ashish Sharma [Inde] ; Ashok Kumar [Inde] ; Alka Jha [Inde] ; Anunay Agarwal [Inde] ; Anoop Misra [Inde]The impact of obesity on inflammatory markers used in the assessment of disease activity in rheumatoid arthritis – a cross-sectional study
000098 (2020) Seda Colak [Turquie] ; Emre Tekgoz [Turquie] ; Muhammet Cinar [Turquie] ; Sedat Yilmaz [Turquie]The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients.
000116 (2020) Xi-Ying Wang [République populaire de Chine] ; Fen Zhang [République populaire de Chine] ; Chi Zhang [République populaire de Chine] ; Liang-Rong Zheng [République populaire de Chine] ; Jian Yang [République populaire de Chine]The Biomarkers for Acute Myocardial Infarction and Heart Failure
000145 (2020) Yunze Li [République populaire de Chine] ; Yixin Yang [République populaire de Chine] ; Jinwan Guo [République populaire de Chine] ; Xuejiao Guo [République populaire de Chine] ; Zhiying Feng [République populaire de Chine] ; Xuli Zhao [République populaire de Chine]Spinal NF-kB upregulation contributes to hyperalgesia in a rat model of advanced osteoarthritis
000156 (2020) Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000333 (2020) Michaela Koehm [Allemagne] ; Matthew J. Mcintosh [États-Unis] ; Michael W. Hofmann [Allemagne] ; Varghese Abraham [États-Unis] ; Cem Gabay [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Arthur Kavanaugh [États-Unis] ; Harald Burkhardt [Allemagne] ; Frank Behrens [Allemagne]Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies.
000334 (2020) Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège]Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000394 (2020) Alberto Meneguzzo ; Annalisa Lazzarotto ; Mauro AlaibacEruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
000435 (2020) Dianna Wolfe [Canada] ; Salmaan Kanji [Canada] ; Fatemeh Yazdi [Canada] ; Pauline Barbeau [Canada] ; Danielle Rice [Canada] ; Andrew Beck [Canada] ; Claire Butler [Canada] ; Leila Esmaeilisaraji [Canada] ; Becky Skidmore [Canada] ; David Moher [Canada] ; Brian Hutton [Canada]Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations
000443 (2020) Judith Sautner [Autriche] ; Rudolf Puchner [Autriche] ; Alois Alkin [Autriche] ; Herwig Pieringer [Royaume-Uni]Depression: a common comorbidity in women with rheumatoid arthritis—results from an Austrian cross-sectional study
000445 (2020) A. Charlotte M. T. De Wolf ; Carla A. Herberts ; Marcel H. N. HoefnagelDawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised
000552 (2020) Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni]COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
000573 (2020) Izabela Szczygielska ; El Bieta Hernik ; Agnieszka Gazda ; Beata Kołodziejczyk ; Piotr GietkaAssessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
000574 (2020) Alexandra Erath [États-Unis] ; Stacie B. Dusetzina [États-Unis]Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
000624 (2015) Raja Atreya [Allemagne] ; Ulrike Billmeier [Allemagne] ; Timo Rath [Allemagne] ; Jonas Mudter [Allemagne] ; Michael Vieth [Allemagne] ; Helmut Neumann [Allemagne] ; Markus F. Neurath [Allemagne]First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "assessment" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "assessment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    assessment
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021